Therese Buskas Selected Research

Peptide T

2/2009	Increasing the antigenicity of synthetic tumor-associated carbohydrate antigens by targeting Toll-like receptors.
10/2007	Robust immune responses elicited by a fully synthetic three-component vaccine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Therese Buskas Research Topics

Disease

6	Neoplasms (Cancer) 01/2012 - 07/2004
1	Breast Neoplasms (Breast Cancer) 01/2012
1	Inhalation anthrax 05/2011
1	Infections 05/2011
1	Anthrax 12/2006

Drug/Important Bio-Agent (IBA)

5	VaccinesIBA 01/2012 - 09/2005
5	CarbohydratesIBA 05/2011 - 09/2005
4	AntigensIBA 01/2012 - 07/2004
4	GlycopeptidesIBA 01/2012 - 09/2005
3	Immunoglobulin G (IgG)IBA 01/2012 - 10/2007
3	AntibodiesIBA 01/2012 - 10/2007
3	EpitopesIBA 01/2012 - 10/2007
3	Carrier Proteins (Binding Protein)IBA 02/2009 - 07/2004
2	Peptide TIBA 02/2009 - 10/2007
2	Synthetic Vaccines (Recombinant Vaccines)IBA 02/2009 - 10/2007
2	Cancer VaccinesIBA 02/2009 - 10/2007
1	Proteins (Proteins, Gene)FDA Link 01/2012
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2012
1	anthrax toxin (anthrax lethal factor)IBA 05/2011
1	4,6- dideoxy- 4- (3- hydroxy- 3- methylbutanamido)- 2- O- methylglucopyranoseIBA 05/2011
1	TrisaccharidesIBA 05/2011
1	Glycoproteins (Glycoprotein)IBA 09/2009
1	GlycolipidsIBA 09/2009
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2009
1	MucinsIBA 02/2009
1	Immune Sera (Antisera)IBA 02/2009
1	monophosphoryl lipid AIBA 02/2009
1	OligosaccharidesIBA 12/2006
1	Tn antigenIBA 09/2005

Therapy/Procedure

2	Immunotherapy 09/2009 - 02/2009